Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology (Q22241650)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology |
scientific article |
Statements
Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology (English)
Janis M Miyasaki
Janis M
Miyasaki
Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
James J Marriott
Gary Gronseth
Paul W O'Connor
1 reference
1 reference
1 reference
1 reference
Identifiers
2 references
2 references
2 references